Combination chemotherapy comprising orally administered UFT and leucovorin against a human prostate carcinoma cell line (PC-3) in nude mice

Y. Sumiyoshi, K. Hashine, M. Akiyama, Hiroyoshi Doihara, H. Satake

Research output: Contribution to journalArticle

Abstract

We evaluated the efficacy of combination chemotherapy comprising orally administered UFT (20 mg/kg) with leucovorin (100 mg/kg) against a human prostate carcinoma cell line (PC-3) in nude mice. Our results showed that the combined treatment of UFT and leucovorin against PC-3 was significantly more effective than no therapy, or leucovorin therapy alone (p <0.1), with only a very small decrease in body-weight being noted in the mice. The histological change of degeneration and/or necrosis was observed in the group receiving the combined therapy. These results suggest that combination chemotherapy comprising UFT with leucovorin may be useful for the treatment of prostatic cancer.

Original languageEnglish
Pages (from-to)857-860
Number of pages4
JournalNishinihon Journal of Urology
Volume56
Issue number8
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Leucovorin
Combination Drug Therapy
Nude Mice
Prostate
Carcinoma
Cell Line
Therapeutics
Prostatic Neoplasms
Necrosis
Body Weight

Keywords

  • biochemical modulation
  • leucovorin
  • prostate carcinoma
  • UFT

ASJC Scopus subject areas

  • Urology

Cite this

Combination chemotherapy comprising orally administered UFT and leucovorin against a human prostate carcinoma cell line (PC-3) in nude mice. / Sumiyoshi, Y.; Hashine, K.; Akiyama, M.; Doihara, Hiroyoshi; Satake, H.

In: Nishinihon Journal of Urology, Vol. 56, No. 8, 1994, p. 857-860.

Research output: Contribution to journalArticle

@article{5536822c312a4d72a81fbe925df862e9,
title = "Combination chemotherapy comprising orally administered UFT and leucovorin against a human prostate carcinoma cell line (PC-3) in nude mice",
abstract = "We evaluated the efficacy of combination chemotherapy comprising orally administered UFT (20 mg/kg) with leucovorin (100 mg/kg) against a human prostate carcinoma cell line (PC-3) in nude mice. Our results showed that the combined treatment of UFT and leucovorin against PC-3 was significantly more effective than no therapy, or leucovorin therapy alone (p <0.1), with only a very small decrease in body-weight being noted in the mice. The histological change of degeneration and/or necrosis was observed in the group receiving the combined therapy. These results suggest that combination chemotherapy comprising UFT with leucovorin may be useful for the treatment of prostatic cancer.",
keywords = "biochemical modulation, leucovorin, prostate carcinoma, UFT",
author = "Y. Sumiyoshi and K. Hashine and M. Akiyama and Hiroyoshi Doihara and H. Satake",
year = "1994",
language = "English",
volume = "56",
pages = "857--860",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "8",

}

TY - JOUR

T1 - Combination chemotherapy comprising orally administered UFT and leucovorin against a human prostate carcinoma cell line (PC-3) in nude mice

AU - Sumiyoshi, Y.

AU - Hashine, K.

AU - Akiyama, M.

AU - Doihara, Hiroyoshi

AU - Satake, H.

PY - 1994

Y1 - 1994

N2 - We evaluated the efficacy of combination chemotherapy comprising orally administered UFT (20 mg/kg) with leucovorin (100 mg/kg) against a human prostate carcinoma cell line (PC-3) in nude mice. Our results showed that the combined treatment of UFT and leucovorin against PC-3 was significantly more effective than no therapy, or leucovorin therapy alone (p <0.1), with only a very small decrease in body-weight being noted in the mice. The histological change of degeneration and/or necrosis was observed in the group receiving the combined therapy. These results suggest that combination chemotherapy comprising UFT with leucovorin may be useful for the treatment of prostatic cancer.

AB - We evaluated the efficacy of combination chemotherapy comprising orally administered UFT (20 mg/kg) with leucovorin (100 mg/kg) against a human prostate carcinoma cell line (PC-3) in nude mice. Our results showed that the combined treatment of UFT and leucovorin against PC-3 was significantly more effective than no therapy, or leucovorin therapy alone (p <0.1), with only a very small decrease in body-weight being noted in the mice. The histological change of degeneration and/or necrosis was observed in the group receiving the combined therapy. These results suggest that combination chemotherapy comprising UFT with leucovorin may be useful for the treatment of prostatic cancer.

KW - biochemical modulation

KW - leucovorin

KW - prostate carcinoma

KW - UFT

UR - http://www.scopus.com/inward/record.url?scp=0028071585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028071585&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 857

EP - 860

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 8

ER -